Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity

Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity

Myelofibrosis is a rare myeloproliferative disorder. The detailed descriptions of myelofibrosis in children and adolescents is limited to a few case series and case reports describing fewer than 100 patients, thus suggesting the extreme rarity of this condition prior to adulthood. Though pediatric p...

Full description

Bibliographic Details
Main Authors: Fabiola Guerra, Vincenzo L’Imperio, Sonia Bonanomi, Marco Spinelli, Tiziana Angela Coliva, Fabiola Dell’Acqua, Giulia Maria Ferrari, Paola Corti, Adriana Balduzzi, Andrea Biondi, Fabio Pagni, Francesco Saettini
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Pediatrics
Subjects:
myelofibrosis
bone marrow
reticulin fibrosis
autoimmune myelofibrosis
inborn errors of immunity
pediatric immune myelofibrosis
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1031687/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.1031687/full

Similar Items